COMMUNIQUÉS West-GlobeNewswire

PetMed Express D/B/A 1-800-PetMeds to Announce its Second Quarter Financial Results on October 22, 2018
15/10/2018
DELRAY BEACH, Fla., Oct. 15, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter ended September 30, 2018 on Monday, October 22, 2018 at 8:00 A.M. Eastern [...]
Samumed Announces Sponsorship of Knee Osteoarthritis Registry Study
15/10/2018
Collaboration will prospectively evaluate the natural history of knee osteoarthritis progression SAN DIEGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today its sponsorship of a registry study in [...]
Rhythm Pharmaceuticals Appoints Murray W. Stewart, M.D., as Chief Medical Officer
15/10/2018
BOSTON, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
Sarepta and Lysogene Announce Exclusive License Agreement for LYS-SAF302, a Late-stage Gene Therapy for the Treatment of MPS IIIA, and Grant of Option Rights to an Additional CNS Gene Therapy Candidate
15/10/2018
-- Expands Sarepta’s portfolio to as many as 14 gene therapy programs -- -- Mucopolysaccharidosis type IIIA (MPS IIIA), also called Sanfilippo syndrome type A, is a rare, severe and fatal inherited neurodegenerative [...]
Mustang Bio Appoints Martina A. Sersch, M.D., Ph.D., as Chief Medical Officer
15/10/2018
NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell ( [...]
Avalon GloboCare Announces Grand Opening of Newly Renovated Headquarters in New Jersey
15/10/2018
FREEHOLD, N.J., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies and therapeutics, announced today the grand opening of their newly renovated [...]
Inovio’s Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses in Preclinical Studies
15/10/2018
Article in Journal of Infectious Diseases Supports Rationale For Inovio’s Ebola Vaccine Stockpile Program PLYMOUTH MEETING, Pa., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced [...]
Extendicare Announces October 2018 Dividend of C$0.04 per Share
15/10/2018
MARKHAM, Ontario, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
IRIDEX Announces Appointment of Robert E. Grove, Ph.D. to its Board of Directors
15/10/2018
MOUNTAIN VIEW, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Dr. Robert Grove to the Company’s Board of Directors effective October 15, 2018. Concurrently [...]
Savara Completes Enrollment in Pivotal Molgradex Impala Clinical Study for the Treatment of aPAP
15/10/2018
Top Line Results Expected in Q2 2019 AUSTIN, Texas, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced completion of the target enrollment of 135 patients in [...]
Tyme Appoints Former Kite and Celgene Executive, Michele Korfin, as Chief Commercial Officer
15/10/2018
NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies Inc, (Nasdaq: TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced the appointment [...]
CTD Holdings Announces Plans to Broaden its Expanded Access Program for Trappsol® Cyclo™
15/10/2018
Company expects to provide its drug to new patients in early 2019 ALACHUA, Fla., Oct. 15, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin- [...]
Delcath Expands Rollout of Registration Trial in Metastatic Ocular Melanoma
15/10/2018
Seven Cancer Centers in United States Open for Enrollment in Amended Trial NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of [...]
Krystal Biotech Announces Positive Interim Results from Placebo-Controlled Phase 1/2 Clinical Trial of KB103
15/10/2018
KB103 is Krystal’s first "off-the-shelf", topical, gene therapy candidate to treat patients suffering from Dystrophic Epidermolysis Bullosa. Results on 2 patients met all primary efficacy (presence of functional COL7 [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
15/10/2018
Villepinte (France), le 15 octobre 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur [...]
PacBio Long-Read Sequencing Featured at ASHG Annual Meeting
15/10/2018
Highlights include release of new chemistry and more than 25 presentations demonstrating utility of SMRT Sequencing for human genetics applications MENLO PARK, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Pacific [...]
Retrotope Presents Data Demonstrating Arrest of Disease Progression with Treatment of RT001 in Patients with Infantile Neuroaxonal Dystrophy (INAD)
15/10/2018
Results presented at the 2018 National Organization for Rare Disorders (NORD) Rare Diseases & Orphan Products Breakthrough Summit® LOS ALTOS, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Retrotope today reported new [...]
Theratechnologies Appoints New Board Member
15/10/2018
MONTREAL, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced the appointment of Mr. Gary Littlejohn as a new independent member to its Board of Directors. “Gary brings [...]
Theratechnologies nomme un nouveau membre à son conseil d’administration
15/10/2018
MONTRÉAL, 15 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Société) (TSX: TH) a annoncé aujourd’hui la nomination de M. Gary Littlejohn à titre d’administrateur indépendant du conseil d’administration de la [...]

Pages